• Gamifying Vision: How Mobile Gaming Is Tracking Vision Degradation in Patients

    Jun 15 | Diagnostics World News | Tilak Healthcare aims to combine video games with medical expertise so that the same vision monitoring tools that are reliable and useful for doctors will be playful and fun for users. If Tilak can achieve that, the company tools will be “sticky” enough to have a longstanding impact on the healthcare process for patients. More
  • AI Algorithms Match Pathologists In Quantifying Tumor Cellularity

    Jun 09 | Diagnostics World News | Artificial intelligence (AI) algorithms were recently found to perform on par with pathologists when it came to quantifying tumor cellularity, an increasingly common measure of patient response to neoadjuvant therapy for breast cancer. That was one of the key findings of the Breast Pathology Quantitative Biomarkers (BreastPathQ) Challenge. More
  • NIH, CDC Public Health Initiative Examines Impact of At-Home COVID-19 Testing

    Jun 07 | Diagnostics World News | A new public health initiative is looking to determine whether widespread access to rapid at-home antigen tests can help reduce the spread of SARS-CoV-2, the virus that causes COVID-19. Dubbed “Say Yes! COVID Test,” the initiative launched by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) is zeroing in on Pitt County, N.C., and Chattanooga/Hamilton County, Tenn. More
  • Diagnostics Funding for Infectious Diseases, Applied NGS: Follow the Money

    Jun 03 | Diagnostics World News | NGS turnkey diagnostics, noninvasive prenatal testing with simplified sample collection, infection disease diagnostics, and more. More
  • New COVID Diagnostics, Pandemic Sciences Centre Launches, New Products

    Jun 01 | Diagnostics World News | University of Oxford launches a new Pandemic Sciences Centre, Quest Diagnostics and Paige collaborate on AI for diagnostics, new products from Waters and Essenlix Corp, and COVID updates from Advanced Biological Laboratories, Ortho Clinical Diagnostics, Thermo Fisher. More
  • Synthetic Data Helps AI Train To Classify Brain Tumors

    May 27 | Diagnostics World News | Over the past year, Michigan Medicine and Synthetaic have been collaborating to generate synthetic data to improve the rate at which brain tumors get accurately diagnosed intraoperatively. The initiative involves using a generative adversarial network to “grow" data since large public repositories do not contain the kind of images needed to guide real-time decision-making about which surgery is best for patients. More
  • Diagnostic Host Response Tests Digging Deeper For Answers

    May 26 | Diagnostics World News | Today the term “presymptomatic” is thrown into casual conversations around the dinner table, and large diagnostic companies are interested in producing products providing presymptomatic notice of infection with a pathogen. In fact, new host response bacterial-viral (HR-B/V) tests that could offer an early warning system for infections. More
  • Advanced High-End Microbiological Incubators: Protecting Test Samples, Laboratory Personnel and Public Health during the COVID-19 Pandemic

    May 24 | Diagnostics World News | Diagnostic testing continues to play a vital role in protecting public health throughout the COVID-19 pandemic. However, we should not overlook the importance of using workflows that safeguard the health of medical laboratory personnel by preventing potential exposure to the SARS-CoV-2 virus. This is of utmost significance given the high volume of tests processed every day, increasing the risk to laboratory teams. More
  • New Medication Insight Reports for 23andMe+ Members On Depression Drug, Blood Thinner

    May 20 | Diagnostics World News | 23andMe released two new medication insight reports last week as part of the company’s 23andMe+ membership. The two new reports provide medication insights on how a person’s CYP2C19 metabolizer profile may impact therapies with citalopram, a blood thinner, and clopidogrel, an antidepressant. More
  • New Assay Quickly Profiles Patient Immune Response In The Emergency Room

    May 19 | Diagnostics World News | When patients are battling any kind of infection, the focus is invariably more on the bug in their system than their immune response to its presence. Yet overactivation of the body’s infection-fighting processes is what leads to conditions like sepsis—a leading cause of death in hospitals. More
View more articles



Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.